Follow the people · Insider
John E. Bishop
John E. Bishop files insider transactions with the SEC as an officer of Ardelyx (ARDX). We hold 3 disclosed purchases and sales filed since 22 February 2006, 1 of them in the last 90 days.
- Files forARDX
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure25 August 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 23 January 2026 — 21 August 2026Officer · Ardelyx (ARDX)13 Form 4 lines · source: SEC Form 4
- Filed 27 February 2023 — 30 January 2024Chief Technology Officer · Lyra Therapeutics (LYRA)2 Form 4 lines · source: SEC Form 4
- Filed 14 June 2021 — 14 October 2022SVP, Chief Technology Officer · Forma Therapeutics Holdings (FMTX)7 Form 4 lines · source: SEC Form 4
- Filed 17 February 2006 — 19 May 2016Senior VP, Pharmaceutical Scie · Momenta Pharmaceuticals (MNTA)269 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 17,281 shares of ArdelyxSEC Form 425 August 2026Common Stock · traded 21 August 2026 · filed 25 August 2026
- ▼ sold on the open market 2,469 shares of ArdelyxSEC Form 425 August 2026Common Stock · traded 21 August 2026 · filed 25 August 2026
- ▼ sold on the open market 2,306 shares of ArdelyxSEC Form 422 May 2026Common Stock · traded 21 May 2026 · filed 22 May 2026
- ▼ sold on the open market 2,792 shares of ArdelyxSEC Form 423 February 2026Common Stock · traded 20 February 2026 · filed 23 February 2026
- ▼ sold on the open market 386 shares of ArdelyxSEC Form 423 February 2026Common Stock · traded 20 February 2026 · filed 23 February 2026
- ▼ sold on the open market 1 share of ArdelyxSEC Form 423 February 2026Common Stock · traded 20 February 2026 · filed 23 February 2026
- ▼ sold on the open market 2,792 shares of ArdelyxSEC Form 423 February 2026Common Stock · traded 20 February 2026 · filed 23 February 2026
- ▼ sold on the open market 386 shares of ArdelyxSEC Form 423 February 2026Common Stock · traded 20 February 2026 · filed 23 February 2026
- ▼ sold on the open market 1 share of ArdelyxSEC Form 423 February 2026Common Stock · traded 20 February 2026 · filed 23 February 2026
- was granted 124,330 shares of ArdelyxSEC Form 426 January 2026Common Stock · traded 23 January 2026 · filed 26 January 2026
- was granted 186,500 shares of Ardelyx (a derivative holding)SEC Form 426 January 2026Stock Option (Right to Buy) · traded 23 January 2026 · filed 26 January 2026
- was granted 186,500 shares of Ardelyx (a derivative holding)SEC Form 426 January 2026Stock Option (Right to Buy) · traded 23 January 2026 · filed 26 January 2026
- was granted 124,330 shares of ArdelyxSEC Form 426 January 2026Common Stock · traded 23 January 2026 · filed 26 January 2026
- was granted 200,000 shares of Lyra Therapeutics (a derivative holding)SEC Form 41 February 2024Stock Options · traded 30 January 2024 · filed 1 February 2024
- was granted 220,000 shares of Lyra Therapeutics (a derivative holding)SEC Form 428 February 2023Stock Option · traded 27 February 2023 · filed 28 February 2023
- returned to the issuer 67,000 shares of Forma Therapeutics Holdings (a derivative holding)SEC Form 414 October 2022Stock Option (Right to Buy) · traded 14 October 2022 · filed 14 October 2022
- returned to the issuer 38,930 shares of Forma Therapeutics Holdings (a derivative holding)SEC Form 414 October 2022Stock Option (Right to Buy) · traded 14 October 2022 · filed 14 October 2022
- disposed of in a tender offer 47,950 shares of Forma Therapeutics HoldingsSEC Form 414 October 2022Common Stock · traded 14 October 2022 · filed 14 October 2022
- was granted 38,930 shares of Forma Therapeutics Holdings (a derivative holding)SEC Form 42 March 2022Stock Option (Right to Buy) · traded 28 February 2022 · filed 2 March 2022
- was granted 25,950 shares of Forma Therapeutics HoldingsSEC Form 42 March 2022Common Stock · traded 28 February 2022 · filed 2 March 2022
- was granted 67,000 shares of Forma Therapeutics Holdings (a derivative holding)SEC Form 415 June 2021Stock Option (Right to Buy) · traded 14 June 2021 · filed 15 June 2021
- was granted 22,000 shares of Forma Therapeutics HoldingsSEC Form 415 June 2021Common Stock · traded 14 June 2021 · filed 15 June 2021
- ▼ sold on the open market 397 shares of Momenta PharmaceuticalsSEC Form 423 May 2016Common Stock · traded 19 May 2016 · filed 23 May 2016
- ▼ sold on the open market 387 shares of Momenta PharmaceuticalsSEC Form 423 May 2016Common Stock · traded 19 May 2016 · filed 23 May 2016
- had shares withheld for tax on 6,206 shares of Momenta PharmaceuticalsSEC Form 419 April 2016Common Stock · traded 18 April 2016 · filed 19 April 2016
- ▼ sold on the open market 2,843 shares of Momenta PharmaceuticalsSEC Form 419 April 2016Common Stock · traded 19 April 2016 · filed 19 April 2016
- was granted 60,000 shares of Momenta PharmaceuticalsSEC Form 415 April 2016Common Stock · traded 13 April 2016 · filed 15 April 2016
- ▼ sold on the open market 227 shares of Momenta PharmaceuticalsSEC Form 424 February 2016Common Stock · traded 22 February 2016 · filed 24 February 2016
- ▼ sold on the open market 102 shares of Momenta PharmaceuticalsSEC Form 424 February 2016Common Stock · traded 23 February 2016 · filed 24 February 2016
- ▼ sold on the open market 404 shares of Momenta PharmaceuticalsSEC Form 422 February 2016Common Stock · traded 19 February 2016 · filed 22 February 2016
- ▼ sold on the open market 1,576 shares of Momenta PharmaceuticalsSEC Form 422 February 2016Common Stock · traded 19 February 2016 · filed 22 February 2016
- ▼ sold on the open market 868 shares of Momenta PharmaceuticalsSEC Form 422 February 2016Common Stock · traded 22 February 2016 · filed 22 February 2016
- ▼ sold on the open market 272 shares of Momenta PharmaceuticalsSEC Form 419 February 2016Common Stock · traded 18 February 2016 · filed 19 February 2016
- ▼ sold on the open market 85 shares of Momenta PharmaceuticalsSEC Form 419 February 2016Common Stock · traded 19 February 2016 · filed 19 February 2016
- was granted 17,100 shares of Momenta PharmaceuticalsSEC Form 411 February 2016Common Stock · traded 9 February 2016 · filed 11 February 2016
- was granted 34,200 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 411 February 2016Stock Option (Right to Buy) · traded 9 February 2016 · filed 11 February 2016
- ▼ sold on the open market 140 shares of Momenta PharmaceuticalsSEC Form 423 November 2015Common Stock · traded 20 November 2015 · filed 23 November 2015
- ▼ sold on the open market 328 shares of Momenta PharmaceuticalsSEC Form 423 November 2015Common Stock · traded 20 November 2015 · filed 23 November 2015
- ▼ sold on the open market 80 shares of Momenta PharmaceuticalsSEC Form 423 November 2015Common Stock · traded 23 November 2015 · filed 23 November 2015
- ▼ sold on the open market 76 shares of Momenta PharmaceuticalsSEC Form 420 November 2015Common Stock · traded 18 November 2015 · filed 20 November 2015
- ▼ sold on the open market 574 shares of Momenta PharmaceuticalsSEC Form 420 November 2015Common Stock · traded 19 November 2015 · filed 20 November 2015
- ▼ sold on the open market 312 shares of Momenta PharmaceuticalsSEC Form 418 November 2015Common Stock · traded 17 November 2015 · filed 18 November 2015
- ▼ sold on the open market 140 shares of Momenta PharmaceuticalsSEC Form 424 August 2015Common Stock · traded 20 August 2015 · filed 24 August 2015
- ▼ sold on the open market 330 shares of Momenta PharmaceuticalsSEC Form 424 August 2015Common Stock · traded 20 August 2015 · filed 24 August 2015
- ▼ sold on the open market 79 shares of Momenta PharmaceuticalsSEC Form 424 August 2015Common Stock · traded 21 August 2015 · filed 24 August 2015
- ▼ sold on the open market 573 shares of Momenta PharmaceuticalsSEC Form 420 August 2015Common Stock · traded 19 August 2015 · filed 20 August 2015
- ▼ sold on the open market 312 shares of Momenta PharmaceuticalsSEC Form 419 August 2015Common Stock · traded 17 August 2015 · filed 19 August 2015
- ▼ sold on the open market 2,840 shares of Momenta PharmaceuticalsSEC Form 419 August 2015Common Stock · traded 18 August 2015 · filed 19 August 2015
- ▼ sold on the open market 76 shares of Momenta PharmaceuticalsSEC Form 419 August 2015Common Stock · traded 18 August 2015 · filed 19 August 2015
- exercised options over 2,554 shares of Momenta PharmaceuticalsSEC Form 422 June 2015Common Stock · traded 19 June 2015 · filed 22 June 2015
- ▼ sold on the open market 2,554 shares of Momenta PharmaceuticalsSEC Form 422 June 2015Common Stock · traded 19 June 2015 · filed 22 June 2015
- exercised options over 18,720 shares of Momenta PharmaceuticalsSEC Form 422 June 2015Common Stock · traded 19 June 2015 · filed 22 June 2015
- ▼ sold on the open market 18,720 shares of Momenta PharmaceuticalsSEC Form 422 June 2015Common Stock · traded 19 June 2015 · filed 22 June 2015
- exercised options over 2,554 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 422 June 2015Stock Option (Right to Buy) · traded 19 June 2015 · filed 22 June 2015
- exercised options over 18,720 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 422 June 2015Stock Option (Right to Buy) · traded 19 June 2015 · filed 22 June 2015
- exercised options over 784 shares of Momenta PharmaceuticalsSEC Form 419 June 2015Common Stock · traded 17 June 2015 · filed 19 June 2015
- ▼ sold on the open market 784 shares of Momenta PharmaceuticalsSEC Form 419 June 2015Common Stock · traded 17 June 2015 · filed 19 June 2015
- exercised options over 14,966 shares of Momenta PharmaceuticalsSEC Form 419 June 2015Common Stock · traded 18 June 2015 · filed 19 June 2015
- ▼ sold on the open market 14,966 shares of Momenta PharmaceuticalsSEC Form 419 June 2015Common Stock · traded 18 June 2015 · filed 19 June 2015
- exercised options over 9,563 shares of Momenta PharmaceuticalsSEC Form 419 June 2015Common Stock · traded 18 June 2015 · filed 19 June 2015
- ▼ sold on the open market 9,563 shares of Momenta PharmaceuticalsSEC Form 419 June 2015Common Stock · traded 18 June 2015 · filed 19 June 2015
- ▼ sold on the open market 11,000 shares of Momenta PharmaceuticalsSEC Form 419 June 2015Common Stock · traded 18 June 2015 · filed 19 June 2015
- exercised options over 784 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 419 June 2015Stock Option (Right to Buy) · traded 17 June 2015 · filed 19 June 2015
- exercised options over 14,966 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 419 June 2015Stock Option (Right to Buy) · traded 18 June 2015 · filed 19 June 2015
- exercised options over 9,563 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 419 June 2015Stock Option (Right to Buy) · traded 18 June 2015 · filed 19 June 2015
- ▼ sold on the open market 65 shares of Momenta PharmaceuticalsSEC Form 427 May 2015Common Stock · traded 26 May 2015 · filed 27 May 2015
- ▼ sold on the open market 69 shares of Momenta PharmaceuticalsSEC Form 427 May 2015Common Stock · traded 26 May 2015 · filed 27 May 2015
- ▼ sold on the open market 120 shares of Momenta PharmaceuticalsSEC Form 427 May 2015Common Stock · traded 26 May 2015 · filed 27 May 2015
- ▼ sold on the open market 227 shares of Momenta PharmaceuticalsSEC Form 421 May 2015Common Stock · traded 20 May 2015 · filed 21 May 2015
- ▼ sold on the open market 218 shares of Momenta PharmaceuticalsSEC Form 420 May 2015Common Stock · traded 19 May 2015 · filed 20 May 2015
- ▼ sold on the open market 406 shares of Momenta PharmaceuticalsSEC Form 420 May 2015Common Stock · traded 19 May 2015 · filed 20 May 2015
- exercised options over 7,500 shares of Momenta PharmaceuticalsSEC Form 413 May 2015Common Stock · traded 11 May 2015 · filed 13 May 2015
- ▼ sold on the open market 7,500 shares of Momenta PharmaceuticalsSEC Form 413 May 2015Common Stock · traded 11 May 2015 · filed 13 May 2015
- exercised options over 26,125 shares of Momenta PharmaceuticalsSEC Form 413 May 2015Common Stock · traded 11 May 2015 · filed 13 May 2015
- ▼ sold on the open market 26,125 shares of Momenta PharmaceuticalsSEC Form 413 May 2015Common Stock · traded 11 May 2015 · filed 13 May 2015
- exercised options over 7,500 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 413 May 2015Stock Option (Right to Buy) · traded 11 May 2015 · filed 13 May 2015
- exercised options over 26,125 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 413 May 2015Stock Option (Right to Buy) · traded 11 May 2015 · filed 13 May 2015
- ▼ sold on the open market 493 shares of Momenta PharmaceuticalsSEC Form 48 May 2015Common Stock · traded 6 May 2015 · filed 8 May 2015
- returned to the issuer 6,750 shares of Momenta PharmaceuticalsSEC Form 420 April 2015Common Stock · traded 29 March 2015 · filed 20 April 2015
- had shares withheld for tax on 6,215 shares of Momenta PharmaceuticalsSEC Form 420 April 2015Common Stock · traded 16 April 2015 · filed 20 April 2015
- ▼ sold on the open market 64 shares of Momenta PharmaceuticalsSEC Form 426 February 2015Common Stock · traded 25 February 2015 · filed 26 February 2015
- ▼ sold on the open market 69 shares of Momenta PharmaceuticalsSEC Form 425 February 2015Common Stock · traded 23 February 2015 · filed 25 February 2015
- ▼ sold on the open market 60 shares of Momenta PharmaceuticalsSEC Form 425 February 2015Common Stock · traded 23 February 2015 · filed 25 February 2015
- ▼ sold on the open market 211 shares of Momenta PharmaceuticalsSEC Form 425 February 2015Common Stock · traded 24 February 2015 · filed 25 February 2015
- ▼ sold on the open market 1,541 shares of Momenta PharmaceuticalsSEC Form 423 February 2015Common Stock · traded 19 February 2015 · filed 23 February 2015
- ▼ sold on the open market 227 shares of Momenta PharmaceuticalsSEC Form 423 February 2015Common Stock · traded 20 February 2015 · filed 23 February 2015
- was granted 18,862 shares of Momenta PharmaceuticalsSEC Form 420 February 2015Common Stock · traded 18 February 2015 · filed 20 February 2015
- ▼ sold on the open market 252 shares of Momenta PharmaceuticalsSEC Form 420 February 2015Common Stock · traded 18 February 2015 · filed 20 February 2015
- was granted 37,725 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 420 February 2015Stock Option (Right to Buy) · traded 18 February 2015 · filed 20 February 2015
- ▼ sold on the open market 64 shares of Momenta PharmaceuticalsSEC Form 41 December 2014Common Stock · traded 26 November 2014 · filed 1 December 2014
- ▼ sold on the open market 69 shares of Momenta PharmaceuticalsSEC Form 426 November 2014Common Stock · traded 24 November 2014 · filed 26 November 2014
- ▼ sold on the open market 66 shares of Momenta PharmaceuticalsSEC Form 426 November 2014Common Stock · traded 24 November 2014 · filed 26 November 2014
- ▼ sold on the open market 211 shares of Momenta PharmaceuticalsSEC Form 426 November 2014Common Stock · traded 25 November 2014 · filed 26 November 2014
- ▼ sold on the open market 228 shares of Momenta PharmaceuticalsSEC Form 421 November 2014Common Stock · traded 20 November 2014 · filed 21 November 2014
- ▼ sold on the open market 217 shares of Momenta PharmaceuticalsSEC Form 419 November 2014Common Stock · traded 17 November 2014 · filed 19 November 2014
- ▼ sold on the open market 64 shares of Momenta PharmaceuticalsSEC Form 428 August 2014Common Stock · traded 27 August 2014 · filed 28 August 2014
- ▼ sold on the open market 211 shares of Momenta PharmaceuticalsSEC Form 426 August 2014Common Stock · traded 25 August 2014 · filed 26 August 2014
- ▼ sold on the open market 69 shares of Momenta PharmaceuticalsSEC Form 426 August 2014Common Stock · traded 25 August 2014 · filed 26 August 2014
- ▼ sold on the open market 66 shares of Momenta PharmaceuticalsSEC Form 426 August 2014Common Stock · traded 25 August 2014 · filed 26 August 2014
- ▼ sold on the open market 228 shares of Momenta PharmaceuticalsSEC Form 422 August 2014Common Stock · traded 20 August 2014 · filed 22 August 2014
- ▼ sold on the open market 217 shares of Momenta PharmaceuticalsSEC Form 418 August 2014Common Stock · traded 15 August 2014 · filed 18 August 2014
- ▼ sold on the open market 64 shares of Momenta PharmaceuticalsSEC Form 429 May 2014Common Stock · traded 27 May 2014 · filed 29 May 2014
- ▼ sold on the open market 211 shares of Momenta PharmaceuticalsSEC Form 427 May 2014Common Stock · traded 23 May 2014 · filed 27 May 2014
- ▼ sold on the open market 69 shares of Momenta PharmaceuticalsSEC Form 427 May 2014Common Stock · traded 23 May 2014 · filed 27 May 2014
- ▼ sold on the open market 66 shares of Momenta PharmaceuticalsSEC Form 427 May 2014Common Stock · traded 23 May 2014 · filed 27 May 2014
- ▼ sold on the open market 227 shares of Momenta PharmaceuticalsSEC Form 421 May 2014Common Stock · traded 20 May 2014 · filed 21 May 2014
- ▼ sold on the open market 217 shares of Momenta PharmaceuticalsSEC Form 416 May 2014Common Stock · traded 15 May 2014 · filed 16 May 2014
- ▼ sold on the open market 64 shares of Momenta PharmaceuticalsSEC Form 45 March 2014Common Stock · traded 4 March 2014 · filed 5 March 2014
- ▼ sold on the open market 211 shares of Momenta PharmaceuticalsSEC Form 43 March 2014Common Stock · traded 27 February 2014 · filed 3 March 2014
- ▼ sold on the open market 277 shares of Momenta PharmaceuticalsSEC Form 427 February 2014Common Stock · traded 25 February 2014 · filed 27 February 2014
- ▼ sold on the open market 906 shares of Momenta PharmaceuticalsSEC Form 425 February 2014Common Stock · traded 24 February 2014 · filed 25 February 2014
- ▼ sold on the open market 66 shares of Momenta PharmaceuticalsSEC Form 425 February 2014Common Stock · traded 24 February 2014 · filed 25 February 2014
- ▼ sold on the open market 66 shares of Momenta PharmaceuticalsSEC Form 425 February 2014Common Stock · traded 24 February 2014 · filed 25 February 2014
- was granted 19,312 shares of Momenta PharmaceuticalsSEC Form 420 February 2014Common Stock · traded 18 February 2014 · filed 20 February 2014
- ▼ sold on the open market 216 shares of Momenta PharmaceuticalsSEC Form 420 February 2014Common Stock · traded 19 February 2014 · filed 20 February 2014
- ▼ sold on the open market 217 shares of Momenta PharmaceuticalsSEC Form 420 February 2014Common Stock · traded 19 February 2014 · filed 20 February 2014
- was granted 38,575 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 420 February 2014Stock Option (Right to Buy) · traded 18 February 2014 · filed 20 February 2014
- ▼ sold on the open market 27,159 shares of Momenta PharmaceuticalsSEC Form 410 January 2014Common Stock · traded 9 January 2014 · filed 10 January 2014
- exercised options over 2,498 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 410 January 2014Option to purchase stock · traded 9 January 2014 · filed 10 January 2014
- exercised options over 6,235 shares of Momenta Pharmaceuticals (a derivative holding)SEC Form 410 January 2014Option to purchase stock · traded 9 January 2014 · filed 10 January 2014
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.